Oats Overnight And Unpacking The Ozempic Craze

1 Aug 2024 · 14 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

CPG Week Podcast Notes

Episode Title

Oats Overnight And Unpacking The Ozempic Craze

Episode Overview In this episode of CPG Week, the podcast team discusses updates from the consumer packaged goods (CPG) industry, focusing on Oats Overnight's recent funding and the marketing dynamics surrounding GLP-1 drugs, particularly Ozempic.

Hosts

  • Monica Watrous - Managing Editor of Nosh
  • Brad Avery - Senior Reporter
  • Lucas Southard - Senior Reporter

---

Key Highlights

  1. Nosh Notables Honorable Mentions
  2. Personal Shoutouts:
  3. Omsom's Founders: Vanessa and Kim Pham for their strong messaging campaign for AAPI representation in the food industry.
  4. Norma Chu: CEO of Day Day Cook, recognized for acquiring Omsom.
  5. Jerry Seinfeld: Mentioned for bringing attention to the CPG industry through his Netflix movie "Unfrosted."
  6. Mike Kurtz: Founder of Mike’s Hot Honey, noted for his successful partnerships with various brands.
  1. Oats Overnight Funding Update
  2. Investment Details:
  3. Recently raised $35 million in a Series B round led by Enlightened Hospitality Investments, bringing total funding to $56 million over the last two years.
  4. Focus areas for investment include:
  5. Manufacturing Facilities: Expansion in Ohio and Arizona.
  6. Retail Growth: Currently, retail makes up about 10% of their business, with ambitions to increase this share.
  7. Supply Chain Enhancement: Emphasis on vertical integration and robust R&D for product innovation.
  • Consumer Engagement:
  • Oats Overnight regularly introduces limited-time flavor options to engage their subscriber base, maintaining consumer interest.
  1. The Ozempic Craze and Marketing Strategies
  2. Consumer Trends:
  3. Discussion on the growing reliance on GLP-1 drugs (like Ozempic) for weight management.
  4. Brightfield Group's Q2 Report Findings:
  5. Over 50% of Americans are actively trying to lose weight.
  6. Approximately 3-5% of the population has used semaglutide injections.
  7. Increased interest in products that support weight loss is notable, creating opportunities for CPG brands.
  • Marketing Approaches:
  • Brands are bifurcated in their messaging:
  • Some focus on holistic health, emphasizing gut health alongside weight loss.
  • Others directly target weight loss in their communications, which raises concerns about promoting unhealthy dieting practices.
  1. Industry Trends and Consumer Behavior
  2. Market Response:
  3. Brands like SuperGut are positioned to cater to consumers seeking healthier meal replacements while also addressing weight loss.
  4. Legacy weight loss brands (e.g., SlimFast) are experiencing declines as new, health-focused brands emerge.
  • Social Media Influence:
  • Significant increases in social media discussions around GLP-1 drugs, with a 500% rise in related conversations focusing on success stories and cautionary tales.
  1. Additional Industry News
  2. Cultured Protein Sector: New hires from the beef industry to drive supplier roles.
  3. Kroger & Albertsons Merger: Updates on the merger process.
  4. Keurig Dr Pepper: Reports healthy growth despite declines in coffee products.

---

Conclusion The episode delves into the evolving landscape of the CPG industry, with a spotlight on innovative funding strategies for emerging brands like Oats Overnight, and the ongoing impact of GLP-1 drugs on consumer behavior and marketing dynamics.

For more insights and detailed discussions, listeners are encouraged to subscribe and stay tuned for future episodes.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:05Welcome to the CPG Week podcast by BevNet and Nosh, your source for the latest food and beverage industry News. I'm Monica Watrous, Managing Editor of NOSH, here with my co-hosts Brad Avery and Lucas Southard. If you're enjoying the show, please subscribe on your listening platform of choice. On the podcast today, we're discussing Ozempic and Overnight Oats. But first, we have officially announced our NOSH Notables Class of 2024, which folks can read at nosh.com. And we had a lot of funds sifting through all the submissions, whittling down the final selection. But there are so many more notable individuals in this industry beyond the two dozen listed.

0:46Which honorable mentions would you add, Brad and Lucas? I'll give a quick shout out to Omsom co-founders Vanessa and Kim Pham, who we recognize Norma Chu, the CEO of Day Day Cook, which acquired OmSom earlier this year. But I want to give props to the founders who have really led a strong messaging campaign for AAPI brands and founders and culture through their social media, and also just on a well-deserved acquisition. So that's my pick for an honorable mention. That's a good one, Brad. I'm going to zag a little bit in a nod to last year's Notables where we had some celebrities, a la Snoop Dogg, Barbie, and the gummy bear, which I don't know if that's a celebrity.

1:35But I'm going to give my honorable mention to Jerry Seinfeld. No. Thanks to his somewhat lackluster, in my humble opinion, Netflix movie, Unfrosted. He did bring to light an element of the CPG industry that I think a lot of consumers were not really aware of, which is in terms of how the R &D works, how the sausage is made, or how the Pop-Tarts are made. For that reason, I think he would be honored to accept an honor roll mention as a notable. Yeah, that's a good one. If you want to know my opinions on that, you can listen to our episode where we talked about Unfrosted. For the record, it was not my favorite movie of the year, but I thought it had some good moments.

2:17Monica watched it like three times. Four. Brad, are you still on your Pop-Tart strike? Oh, no, I've had Pop-Tarts. You swore. So my honorable mention for Nosh Notables would be Mike Kurtz, who is the founder of Mike's Hot Honey. This past year just continues to trot out new partnerships with restaurant operators and other packaged food companies. This week we saw an announcement with Bush's Beans, Brad's Favorite. And earlier this year there have been collaborations with Club Crackers, Utz Potato Chips, and even Cinemark Movie Theaters. You can now get your popcorn with Mike's hot honey drizzled on it.

2:58Brad, you wrote this week about Oats Overnight's Series B funding. Can you tell us more? Yes. So this week, Oats Overnight raised$35 million. A round was led by Enlightened Hospitality Investments, which is a first-time investor in the brand, as well as a number of new and existing investors. This is in addition to$21 million that they raised last year. So that's$56 million in two years for a brand that is primarily still e-commerce focused. I was able to talk to CEO Brian Tate and Chief Strategy Officer Nina McKinney on Monday, and they told me that a lot of the focus is to support their new manufacturing facilities in Ohio and Arizona, as well as support for retail expansion.

3:47It's still only give or take 10 % of the business. And so retail is going to continue to be a focus for this brand. It's interesting that a company at this stage is self-manufacturing. Absolutely. And they're trying to also go vertically integrated. And a lot of this round is also for supporting supply chain and shoring that up. They have a very robust R &D schedule. They do limited time flavors constantly for their subscribers. so they're always innovating and that requires a strong supply chain so that's where I think a bulk of the money is going and then retail was also another big aspect of that as well as innovation I used to subscribe to oats overnight I don't anymore not because I don't like it I just eat different breakfast I get bored of the same breakfast but I loved that LTO program that was really fun because they weren't always forthcoming on what the actual flavor profile was sometimes it was like top secret or a mystery flavor and you had to guess.

4:48And I thought it was pretty good too that we talked about other innovations beyond just flavor functionality and in particular protein is a big focus for them. And I asked you why protein because we've been hearing a lot about that and you mentioned Ozempic and GLP-1 drugs being a big reason for pushing the growth of protein in the market right now. So that's something that Oats Over Night is definitely focused on. What also stood out to me was just the sheer amount of staff that they have. I mean, they have a pretty robust labor force. In their story, they said they have about 250 full-time employees, and they were expecting to hire a bunch more.

5:27Well, last year, when we reported on their$21 million raise, they had 250 employees. Now it's about 350, and they're looking to keep hiring. That's a lot of that is production. It is. I mean, to have two facilities. I'm excited to see what comes next from Oats Overnight. I know they're experimenting with other form factors and product lines. They have a protein coffee available for their subscribers. I'm curious whether they'll get out of Oats and do other things along the lines of protein enhanced products or other nutritional convenient products. I'd also like to point out this is the second new investment that we've heard in the breakfast category.

6:11Evergreen closed a$5.4 million round recently, so they make frozen waffles and breakfast sandwiches. And so there is something to be said that as tight as it is to get new capital these days, there are some brands in the especially better for you breakfast category that seem to be doing pretty well. Well, Brad, you mentioned Ozempic, and that brings us to our next topic. We published an exclusive report for BevNet and Nosh Insiders featuring data from the Brightfield Group on the GLP-1 craze. And some of the highlights of the report here are that over half of Americans are actively trying to lose weight, and 69 % of adults are classified as overweight or obese.

6:55approximately 3 % to 5 % of the general population have been using semaglutide injections like Ozempic, Manjaro, Wegovi, others in the market, some compound drugs. For weight management over the past year, it's also a diabetes drug. And Brightfield Group says that that rate of consumption or usage is comparable to products like oat milk lattes and matcha teas. So not an insignificant penetration here. Recent growth in semaglutide use has slowed, but the data suggests that another surge by January is possible, driven by increased consumer interest and new product development. And Brightfield Group uses social listening as part of their research.

7:44They're tracking conversations around semaglutide and reported that those conversations on social media have increased at a rate of 500 % compound monthly growth rate this year, with content trending around success stories, transformation, pictures, before and after, community support, but also cautionary tales about the use of these drugs. This Brightfield report is consistent with a lot of the conversations that I did have at IFT with some of the major ingredient providers there. A lot of them were focusing on this interconnectedness of gut health, low glycemic ingredients, and low glycemic diets, and that's effect on consumers' weight and helping consumers along on this idea of a weight loss journey and a stronger desire and demand from consumers for more products that are GLP-1 companion drugs or alternatives to what we're seeing with Ozempic.

8:50It's good to remember that none of this stuff happens in a vacuum, that people have various interests and will be combining these products with different uses. And in particular, something like gut health combining with GLP-1 drugs makes a lot of sense given what we know about the side effects of a lot of GLP-1 drugs. So an emphasis on And combining these makes perfect sense. From my perspective, that the idea of prebiotics or gut health and brands positioning around this is almost like a dog whistle to helping consumers with their weight loss journey. And so some brands might not be saying necessarily that their product that's full of prebiotic fiber is a weight loss product.

9:37but there does seem to be a understanding from the consumer perspective that the more prebiotics you get in your diet, the more fiber, it might be helpful to helping you lose some weight. The way that brands are responding to this trend is bifurcated. We're seeing some brands who are embracing this idea of healthspan and holistic health and wellness, tying weight loss to other health benefits like gut microbiome and low glycemic index. On the other hand, we're seeing brands that are embracing messaging around weight loss as part of their communications. Belly Welly, the gut health brand, recently sent an email to its subscriber list with messaging around, do you want to lose the last five pounds?

10:28So it's concerning to me to see brands that are hyper-focused on weight loss as part of their messaging and not considering the bigger picture of having a healthy lifestyle or longevity. Right. To the point that I wrote recently about Healthspan and the focus on being healthy when you're younger in order to prolong your fitness throughout your life. And that messaging kind of moved away from weight loss. But now with GLP-1, as you said, we're seeing more brands re-embrace weight control. But what I think is interesting about this is that a lot of the legacy brands that made weight loss their identity are not coming back as a result.

11:18I have some Circonidate in front of me. In the 52 weeks ending July 14th, SlimFast fell 38.2 % in U.S. retail, Mulo and C-Store. It's still a$100 million brand, but compared to the brands that are fast rising in this category, you have Owen, you have Premier, you have Fairlife with their core power. So the brands that made their whole purpose to be weight loss are not catching on. Some of these smaller brands or rising brands that are focused on health are now reintroducing you want to lose five pounds into their messaging. And I think the brands that are doing it well, so SuperGut is the first one that comes to mind.

12:01I've talked to the founder, Mark Washington, who's a notch notable this year, founded the brand in an ode to his sister who was a diabetic and struggled with her weight. And when GLP-1 drugs became a really big trend, he found that this is exactly what his brand was already doing. And it provides a healthy eating alternative, a supplement, whether it's a bar or a shake, that can meet consumers that are looking to help on their weight loss journey, but also are just looking for a healthier meal replacement. There are a lot more insights and data in the Brightfield Group report, which BevNet and Nosh insiders can access.

12:43Here are some other notable bits of news from the week. Cultured protein maker taps beef industry vet, eyes supplier role. Kroger and Albertson's update. Parties agree in Colorado to put mega merger on hold. And Keurig Dr. Pepper sees healthy Q2 growth amid coffee declines. For these stories and more, become an insider at BevNet and Nosh. That wraps up this edition of CPG Week by Bevna and Nosh. Thank you to our audio engineer, Joshua Pratt. Our director is Mike Schneider and our designer is Aaron Willett. If you enjoyed the podcast, please subscribe on your listening platform of choice and we will see you next time.

From the publisher

In this episode:

On this episode of CPG Week, the podcast team teases their Nosh Notables honorable mentions, details the latest investment for a fast-growing food brand and discusses the different marketing approaches food brands are taking in the Ozempic Era.

Nosh managing editor Monica Watrous and senior reporters Brad Avery and Lukas Southard talk about Oats Overnight Series B round and how the brand has built a strong consumer base in ecommerce. The team goes on to dive into the Brightfield Group's exclusive BevNET/Nosh Q2 Report: The GLP-1/Ozempic Craze and reflects on how food brands are marketing around the continuing demand for weight loss solutions related to GLP-1 drugs.

Show Highlights:

0:50 - The team shares their personal honorable mentions for Nosh Notables including a shoutout to Omsom's founders, the creative mind behind Netflix's "Unfrosted" and one of leading names in hot honey.

3:00 - Senior reporter Brad Avery talks about Oats Overnight's recent $35 million investment announced this week. The company appears to be continuing its growth trajectory and resourcing its manufacturing and labor force with the new tranche of capital.

6:45 - Nosh managing editor Monica Watrous explains what was reported in the Brightfield Group's Q2 dive into GLP-1 drugs and how consumers are responding to weight loss solutions in CPG. The conversation harkens back to previous podcast episodes where the team has discussed the growing trend towards weight loss products and how food and beverage brands are positioning around semaglutide drugs like Ozempic and Wegovy. 

About the CPG Week

CPG Week is the podcast that explores the latest happenings in the consumer packaged goods industry. Join our seasoned reporting team as they dish out the week's stories in quick, easy-to-digest episodes. Catch up on the top headlines of the week, dive into exclusive insights with the BevNET and Nosh teams, and set yourself up to make more informed business decisions. Tune in to stay up-to-date on the latest developments in the dynamic world of packaged food and beverage.

New episodes are released every week. Send us comments and suggestions anytime to cpgweek@nosh.com.

Subscribe on Apple Podcasts

More from CPG Week by BevNET & Nosh

All 175 episodes
Oats Overnight And Unpacking The Ozempic CrazeCPG Week by BevNET & Nosh · 14 min
Listen in VO